{
  "compound": "Various (THC, nabilone, smoked cannabis)",
  "condition": "GLAUCOMA",
  "effect_size": "Consistent large effect (25-30%)",
  "study_type": "SYSTEMATIC_REVIEW",
  "source": "NORML:GLAUCOMA_SYSTEMATIC_REVIEW_001",
  "participants": "6 trials reviewed",
  "year": 2015,
  "notes": "Cannabinoids for Glaucoma: Cochrane Systematic Review",
  "confidence": "medium",
  "abstract": "Consistent 25-30% IOP reduction with THC-containing preparations; Short duration (3-4 hours) main limitation; Quality: Moderate"
}